18 results  1 of 1 

1 Whole-Genome and Transcriptome Sequencing Identified NOTCH2 and HES1 as Potential Markers of Response to Imatinib in Desmoid Tumor (Aggressive Fibromatosis): A Phase II Trial Study
Joonha Kwon, Jun Hyeong Lee, Young Han Lee, Jeeyun Lee, Jin-Hee Ahn, Se Hyun Kim, Seung Hyun Kim, Tae Il Kim, Kum-Hee Yun, Young Suk Park, Jeong Eun Kim, Kyu Sang Lee, Jung Kyoon Choi, Hyo Song Kim
Cancer Res Treat.2022;54(4):1240-1255.   Published online 2022 January 17     DOI: http://dx.doi.org/10.4143/crt.2021.1194
      
2 직장에 발생한 거대한 위장관 기질종양의 성공적인 내시경 절제
Seong Jung Kim, Yun Jung, Ran Hong, Jun Lee
Korean J Gastroenterol.2021;78(4):235-239.   Published online 2021 October 25     DOI: http://dx.doi.org/10.4166/kjg.2021.097
      
3 초고령 환자에서 위의 위장관 기질 종양 수술 후 나타난 반복적인 문합부 재발
Hye-Jin Kim, Jae Yong Park, Beom Jin Kim, Jae Gyu Kim, Hee Sung Kim and Joong-Min Park
Korean J Gastroenterol.2020;76(4):206-210.   Published online 2020 October 25     DOI: http://dx.doi.org/10.4166/kjg.2020.76.4.206
      
4 Neuroprotective potential of imatinib in global ischemia-reperfusion-induced cerebral injury: possible role of Janus-activated kinase 2/signal transducer and activator of transcription 3 and connexin 43
Jieying Wang, Taomin Bai, Nana Wang, Hongyan Li, Xiangyang Guo
Korean J Physiol Pharmacol.2020;24(1):11-18.   Published online 2019 December 20     DOI: http://dx.doi.org/10.4196/kjpp.2020.24.1.11
      
5 Factors Influencing Imatinib-Induced Hepatotoxicity
Ji Min Han, Jeong Yee, Yoon Sook Cho, Hye Sun Gwak
Cancer Res Treat.2020;52(1):181-188.   Published online 2019 June 26     DOI: http://dx.doi.org/10.4143/crt.2019.131
      
6 Imatinib-induced hepatitis treated by corticosteroids in a patient with metastatic gastrointestinal stromal tumor
Min Kyu Kang, Heon Ju Lee, Joon Hyuk Choi
Yeungnam Univ J Med.2019;36(2):155-158.   Published online 2019 January 21     DOI: http://dx.doi.org/10.12701/yujm.2019.00115
      
7 A rare case of osteonecrosis of the jaw related to imatinib
Massimo Viviano, Marco Rossi, Serena Cocca
J Korean Assoc Oral Maxillofac Surg.2017;43(2):120-124.   Published online 2017 April 25     DOI: http://dx.doi.org/10.5125/jkaoms.2017.43.2.120
      
8 Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor
Dong-Hoe Koo, Min-Hee Ryu, Kyoung-Mee Kim, Han-Kwang Yang, Akira Sawaki, Seiichi Hirota, Jie Zheng, Bo Zhang, Chin-Yuan Tzen, Chun-Nan Yeh, Toshirou Nishida, Lin Shen, Li-Tzong Chen, Yoon-Koo Kang
Cancer Res Treat.2016;48(4):1155-1166.   Published online 2016 June 24     DOI: http://dx.doi.org/10.4143/crt.2016.187
      
9 A Multi-centric Bioequivalence Trial in Ph+ Chronic Myeloid Leukemia Patients to Assess Bioequivalence and Safety Evaluation of Generic Imatinib Mesylate 400 mg Tablets
Rachna Arora, Manju Sharma, Tausif Monif, Sunil Iyer
Cancer Res Treat.2016;48(3):1120-1129.   Published online 2016 February 12     DOI: http://dx.doi.org/10.4143/crt.2015.436
      
10 Correlation between Computed Tomography and Pathological Findings of Gastrointestinal Stromal Tumors Treated with Imatinib Mesylate
Ki Choon Sim, Beom Jin Park, Na Yeon Han, Deuk Jae Sung, Min Ju Kim, Sung Bum Cho, Hyun Kwon Ha, Hyoung Rae Kim
J Korean Soc Radiol.2014;71(5):239-248.   Published online 2014 October 30     DOI: http://dx.doi.org/10.3348/jksr.2014.71.5.239
      
11 Inhibition of intimal hyperplasia by local perivascular application of rapamycin and imatinib mesilate after carotid balloon injury
Daedo Park, Suh Min Kim, Sang-Il Min, Jongwon Ha, In-Gyu Kim, Seung-Kee Min
J Korean Surg Soc.2013;85(6):296-301.   Published online 2013 November 26     DOI: http://dx.doi.org/10.4174/jkss.2013.85.6.296
   
12 Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™)
Ah Young Cho, Dae Hun Kim, Myung Im, Young Lee, Young Joon Seo, Jeung Hoon Lee
Ann Dermatol.2011;23(Suppl 3):S360-S363.   Published online 2011 December 27     DOI: http://dx.doi.org/10.5021/ad.2011.23.S3.S360
      
13 Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro
Ayhan Bilir, Mine Erguven, Ezgi Ermis, Mine Sencan, Nuray Yazihan
J Gynecol Oncol.2011;22(4):225-232.   Published online 2011 December 5     DOI: http://dx.doi.org/10.3802/jgo.2011.22.4.225
      
14 Imatinib-Mesylate Induced Interstitial Pneumonitis in Two CML Patients
Tae Hoon Kim, Byung Gyu Kim, Sung Woo Cho, Sung Kyun Cho, Hyun-Jung Kim, Young Jin Yuh, Sung Rok Kim
Tuberc Respir Dis.2011;71(3):210-215.   Published online 2011 September 30     DOI: http://dx.doi.org/10.4046/trd.2011.71.3.210
      
15 Efficacy of Imatinib Mesylate Treatment for a Patient with Rheumatoid Arthritis and Who Developed Chronic Myelogenous Leukemia
Hye Kyung Jeon, Young Eun Park, Sung Il Kim, Seong Hu Park, Seung Hoon Baek, Joung Wook Lee, Dong Woo Ha, Hye Won Lee, Joo Seop Chung, Seung Hee Lee, Eun Yup Lee
J Rheum Dis.2011;18(2):118-121.   Published online 2011 July 1     DOI: http://dx.doi.org/10.4078/jrd.2011.18.2.118
   
16 A case of subdural hematoma in patient with chronic myeloid leukemia treated with high-dose imatinib mesylate
Min Sik Kim, Dong Hyun Lee, Yu Rim Lee, Dong Kyun Kim, Suk Hyang Bae, Jin Yeon Hwang, Kyung A Kwon, Suee Lee, Jin Yeong Han, Ki Uk Kim, Sung-Hyun Kim
Korean J Hematol.2010;45(1):73-75.   Published online 2010 March 31     DOI: http://dx.doi.org/10.5045/kjh.2010.45.1.73
      
17 Effect on Cell Cycle Progression by N-Myc Knockdown in SK-N-BE(2) Neuroblastoma Cell Line and Cytotoxicity with STI-571 Compound
Un-Young Yu, Je-Eun Cha, Sun-Young Ju, Kyung-Ah Cho, Eun-Sun Yoo, Kyung-Ha Ryu, So-Youn Woo
Cancer Res Treat.2008;40(1):27-32.   Published online 2008 March 31     DOI: http://dx.doi.org/10.4143/crt.2008.40.1.27
      
18 Reversal of Marrow Fibrosis Following Imatinib Mesylate Therapy in a Patient with Chronic Myelogenous Leukemia Who Was Refractory to Interferon-α
Yeon Seong Kim, Tae Hun Kim, Won Chul Kim, Youn Joo Jeon, Uk Hyun Kil, Hae Kyung Lee, Yeong Sik Kim, Sang Young Rho, Seok Goo Cho
Korean J Hematol.2005;40(2):124-128.   Published online 2005 June 21     DOI: http://dx.doi.org/10.5045/kjh.2005.40.2.124
   

 1 of 1